Please assess the completion status of the following clinical trial:

Trial Title: Cardiox Shunt Detection Technology Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Eighteen (18) years of age or older~* Informed consent documentation understood and signed~* Planned or completed TEE study within the last 12 months~Exclusion Criteria:~* Subjects with a known allergy or sensitivity to Indocyanine Green Dye (ICG) or to Iodide Contrast Dye or Iodides~* Pregnant women or nursing mothers~* Subject unable or unwilling to understand and sign the informed consent~* Subject scheduled for radioactive iodine uptake test (Thyroid test) within 7 days of post screening~* Subjects that have poor renal function such as subjects on dialysis, subjects with a recent history of creatinine \> 2.0 or subjects currently being followed by a nephrologist

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- TCD/Cardiox FDS/TEE testing (Type: EXPERIMENTAL): All patients enrolled will be evaluated with TCD and Cardiox FDS and TEE for the presence of RTLS.

Based on this trial design, predict the completion outcome and termination type (if applicable).